Showing results (1471-1480 of 1,731) with videos related to

Sort By:
Pageof 174
JACC. Advances|February 20, 2024
The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health DisparitiesThomas A Pearson, Debbie Vitalis, Charlotte Pratt, et al.
Human Pathology|March 7, 2025
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entitiesFlorian Viehweger, Justus Gusinde, Nicolai Leege, et al.
The American Journal of Surgical Pathology|April 22, 2024
TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor EntitiesMaximilian Lennartz, Neele Löhr, Doris Höflmayer, et al.
Nature Neuroscience|January 6, 2025
Typical development of synaptic and neuronal properties can proceed without microglia in the cortex and thalamusMary O'Keeffe, Sam A Booker, Darren Walsh, et al.
Nature Communications|January 11, 2022
Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathologyZoeb Jiwaji, Sachin S Tiwari, Rolando X Avilés-Reyes, et al.
Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.
Nature Cancer|February 4, 2022
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expressionLucile Vanhersecke, Maxime Brunet, Jean-Philippe Guégan, et al.
Prostate Cancer and Prostatic Diseases|November 4, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancerNeele Heckmann, Henning Plage, Ronald Simon, et al.
Science Immunology|January 11, 2024
UNC93B1 variants underlie TLR7-dependent autoimmunityChristine Wolf, Ee Lyn Lim, Mohammad Mokhtari, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Pageof 174